Afinitor (everolimus)    (DrugBank: Everolimus)

1 disease
告示番号疾患名(ページ内リンク)臨床試験数
137限局性皮質異形成1

137. 限局性皮質異形成 [臨床試験数:8,薬物数:4(DrugBank:2),標的遺伝子数:1,標的パスウェイ数:50
Searched query = "Focal cortical dysplasia", "FCD"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 8 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03198949
(ClinicalTrials.gov)
May 24, 201813/6/2017A Study Investigating the Anti-epileptic Efficacy of Afinitor (Everolimus) in Patients With Refractory Seizures Who Have Focal Cortical Dysplasia Type II (FCD II)A Prospective, Randomized, Double-blind, Placebo-controlled Cross Over Study Investigating the Anti-epileptic Efficacy of Afinitor (Everolimus) in Patients With Refractory Seizures Who Have Focal Cortical Dysplasia Type II (FCD II)Epilepsy and Focal Cortical Dysplasia IIDrug: Afinitor (everolimus)Yonsei UniversityNULLRecruiting4 Years40 YearsAll26Phase 2Korea, Republic of